Does Kenneth Widder’s Form 4 show QuidelOrtho share purchases or sales?

No. All reported transactions are coded as grants or awards (code A) of derivative securities, specifically restricted stock units. The summary shows no open-market purchases or sales; instead, it reflects compensation-related equity grants that may settle in shares when they vest.

QuidelOrtho director granted new RSU awards

QuidelOrtho Corp director Kenneth J. Widder received several equity-based awards in the form of restricted stock units (RSUs).

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

QuidelOrtho Corp director Kenneth J. Widder received several equity-based awards in the form of restricted stock units (RSUs). On June 25, 2026, he was granted 1,997 premium RSUs, 6,656 converted RSUs, and 15,532 equity grant RSUs, each representing one share of common stock. The RSUs were issued in lieu of certain cash retainer and board service fees under a deferred compensation program and vest on a scheduled basis, including full vesting for one grant on June 25, 2027 and four installments of 1,664 shares between June 25, 2026 and March 25, 2027.

Insider Trade Summary

Grant/Award: 24,185 shares

Grant/Award 3 txns

Insider WIDDER KENNETH J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (Equity Grant)	15,532	$0.00	$0.00
Grant/Award	Restricted Stock Units (Converted)	6,656	$0.00	$0.00
Grant/Award	Restricted Stock Units (Premium)	1,997	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (Equity Grant) — 15,532 contracts (Direct); Restricted Stock Units (Converted) — 6,656 contracts (Direct); Restricted Stock Units (Premium) — 1,997 contracts (Direct)

Footnotes (4)

F1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2. The restricted stock units will vest on June 25, 2027.
F3. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
F4. 1,664 shares vested on June 25, 2026, 1,664 shares will vest on September 25, 2026, 1,664 shares will vest on December 25, 2026, and 1,664 shares will vest on March 25, 2027.

Key Figures

Premium RSU grant: 1,997 units Converted RSU grant: 6,656 units Equity grant RSUs: 15,532 units +3 more

6 metrics

Premium RSU grant 1,997 units Restricted Stock Units (Premium) granted on June 25, 2026

Converted RSU grant 6,656 units Restricted Stock Units (Converted) granted on June 25, 2026

Equity grant RSUs 15,532 units Restricted Stock Units (Equity Grant) granted on June 25, 2026

Single-date vesting June 25, 2027 One RSU grant vests entirely on this date

Installment vesting size 1,664 shares Each installment vesting on four dates from June 25, 2026 to March 25, 2027

Installment vesting dates June 25, 2026 to March 25, 2027 Four vesting tranches of 1,664 shares each

Key Terms

Restricted Stock Units, deferred compensation program, retainer and Board of Director service-related fees

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

deferred compensation program financial

"under a deferred compensation program applicable to participating non-employee directors."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did QuidelOrtho (QDEL) director Kenneth Widder report on this Form 4?

Kenneth J. Widder reported the acquisition of multiple restricted stock unit (RSU) awards tied to QuidelOrtho common stock. These are compensation-related grants, not open-market share purchases or sales, and reflect equity issued for his service as a non-employee director.

How many QuidelOrtho RSUs did Kenneth Widder receive in the latest grant?

He received three RSU awards: 1,997 premium RSUs, 6,656 converted RSUs, and 15,532 equity grant RSUs. Each RSU represents the right to receive one share of QuidelOrtho Corporation common stock, subject to the vesting schedules described in the filing footnotes.

When do Kenneth Widder’s newly reported QuidelOrtho RSUs vest?

One RSU grant vests on June 25, 2027. Another grant vests in four equal installments of 1,664 shares on June 25, 2026, September 25, 2026, December 25, 2026, and March 25, 2027, creating a staggered vesting schedule over these dates.

Are Kenneth Widder’s QuidelOrtho RSUs part of a cashless compensation program?

Yes. The filing notes that certain RSUs were received in lieu of cash payments for retainer and board service-related fees. They are issued under a deferred compensation program for participating non-employee directors, substituting equity awards for cash compensation according to the election.

How will Kenneth Widder’s QuidelOrtho RSUs be settled after vesting?

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. Release of vested RSUs will occur according to Kenneth Widder’s elected deferral schedule under the company’s deferred compensation program for non-employee directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/29/2026 - 06:01 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WIDDER KENNETH J

(Last)

(First)

(Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO

CALIFORNIA

92121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (Equity Grant)	⁽¹⁾	06/25/2026		A		15,532		⁽²⁾	⁽²⁾	Common Stock	15,532	$0	15,532	D
Restricted Stock Units (Converted)	⁽¹⁾	06/25/2026		A		6,656		⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	6,656	$0	6,656	D
Restricted Stock Units (Premium)	⁽¹⁾	06/25/2026		A		1,997		⁽²⁾⁽³⁾	⁽²⁾⁽³⁾	Common Stock	1,997	$0	1,997	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. The restricted stock units will vest on June 25, 2027.

3. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.

4. 1,664 shares vested on June 25, 2026, 1,664 shares will vest on September 25, 2026, 1,664 shares will vest on December 25, 2026, and 1,664 shares will vest on March 25, 2027.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Kenneth J. Widder	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR